International Institute of Medicine & Science, USA
ALAIN L. FYMAT is a medical-physical scientist and an educator. He was educated at the University of Paris-Sorbonne and the University of California at Los Angeles. He is the current President/CEO and Institute Professor at the International Institute of Medicine & Science with a previous appointment as Executive Vice President, Chief Operating Officer and Professor at the Weil Institute of Critical Care Medicine. He was formerly Professor of Radiology, Radiological Sciences, Radiation Medicine (Oncology), Critical Care Medicine, and Physics at several U.S. and European Universities. Previously, he was Deputy Director (Western Region) of the U.S. Department of Veterans Affairs, Veterans Health Administration (Office of Research Oversight), and Director of the Magnetic Resonance Imaging Center and for a time Acting Chair of Radiology at its Loma Linda, California Medical Center. He has extensively published (~ 445 scholarly publications including patents, books & monographs, book chapters, refereed articles). As invited/keynote speaker and member of scientific organizing committees of international congresses and symposia, he has lectured extensively in the USA, Canada, Europe, Africa, and Asia. He has been the recipient of numerous research grants from government, academia and private industry, and has consulted extensively with these entities. He is a Board member of several institutions and Health Advisor of the American Heart & Stroke Association (Coachella Valley Division, California). He is Editor-in-Chief, Honorable Editor or Editor of numerous medical-scientific Journals to which he contributes regularly. He is also a member of the New York Academy of Sciences and the European Union Academy of Sciences and a reviewer for the prestigious UNESCO Newton Prize, United Kingdom National Commission for UNESCO. Dr. Fymat’s current research interests lie at the interface between science and medicine, particularly nanomedicine, nanobiotechnology, cancer/oncology, molecular/personal/precision medicine, human genetics/epigenetics/ecogenetics, neurodegenerative diseases, pharmacology and pharmacogenomics. His most recent publications deal with nanotechnology and cancer, nanochemotherapy, nanoneurology, natural and synthetic immunotherapy, drug delivery across the brain protective barriers, and neurodegenerative disorders (including dementias, epilepsy, Parkinson's and Alzheimer's disease).
Southern Federal University, Russia
Sam Vaknin is Visiting Professor of Psychology, Southern Federal University, Rostov-on-Don, Russia and Professor of Finance and Psychology in CIAPS (Centre for International Advanced and Professional Studies). Sam Vaknin is the author of Malignant Self-love: Narcissism Revisited and other books about personality disorders. His work is cited in hundreds of books and dozens of academic papers. He spent the past 6 years developing Cold Therapy: a treatment modality for Narcissistic Personality Disorder (NPD). Over the years, with dozens of volunteers, he found that it was effective with clients suffering from a major depressive episode as well.
Romania, University of Bucharest
Prof. Radu Mutihac is Chair of Medical Physics Section, University of Bucharest, and works in Neuroscience, Signal Processing, Microelectronics, and Artificial Intelligence. As postdoc/research associate/visiting professor/full professor he has run his research at the University of Bucharest, International Centre for Theoretical Physics (Italy), Ecole Polytechnique (France), Institut Henri Poincaré (France), KU Leuven (Belgium). Data mining and exploratory analysis of neuroimaging time series were addressed during two Fulbright Grants in Neuroscience (Yale University, CT, and University of New Mexico, NM, USA). His research in fused biomedical imaging modalities was carried out at the Johns Hopkins University, National Institutes of Health, and Walter Reed Army Institute of Research, MD, USA. Since 2008, Prof. Mutihac has been nominated PhD student supervisor in the field of Physics at the University of Bucharest, Romania. He is member of the ISMRM, ESMRMB, OHBM, Romanian US Alumni Association, and fellow of Signal Processing and Neural Networks Society IEEE, as well as referee for several journals of the Institute of Physics (London, UK), Neural Networks (Elsevier), IEEE Transactions on Image Processing, and evaluator/expert for the ISMRM, OHBM, ARACIS, CNCSIS, UEFISCDI, The Romanian – U.S. Fulbright Commission, and the European Commission (FP7, H2020).
Edith Cowan University, Australia
Dr Ian James Martins completed his school studies at Cyril Jackson Senior High School, Perth, Western Australia. He completed his Bachelor of Science in 1983 (Pathology, Biochemistry/Anatomy and Human Biology) at the University of Western Australia (UWA). In 1985 he completed his Master of Science in Clinical Biochemistry and completed his PhD in Physiology (1989) studying the role of high density lipoprotein (HDL) in diabetes. He has been the recipient of seeding grants (1985-2000) from the Raine Medical Research Foundation, Athelstan and Amy Saw Research Grant and Hackett Research Foundation. In the past 30 years as a Research Fellow at Edith Cowan University/UWA collaborations with the NHMRC, Commercial Industry, National Institute of Health (USA), Mc Cusker Foundation approx. 3.5 million dollars has been received for medical and scientific research. He has been conferred with the RICHARD KUHN RESEARCH AWARD-2015 ENDOCRINOLOGY AND METABOLISM. He is a reviewer for journals (40) and Chief Editor, International Journal of Diabetes Research (2016-2014). ResearchGate’s analysis www.google.com under Ian James Martins’ name places RG score higher than 96% of the international researchers, H-index of 22, 87 full text publications.
Aristotelian University, Greece
Stavros J. Baloyannis, Professor Emeritus of Neurology at Aristotelian University, Thessaloniki, Greece, born in Thessaloniki. Graduated from the School of Medicine, Aristotelian University. Training in Neurology at Aristotelian University and Institute of Neurology, London, Neuropathology, Institute of Neurology, London, Catholic University of Louvain, University of Pennsylvania, Neuropathology of Auditory pathway, Harvard University, Electron Microscopy University of Pennsylvania, Neuroimmunology, Yale University. Research on Blood Brain Barrier, Mitochondria in Alzheimer’s disease, Synaptogenesis, Neuronal apoptosis, dendritic and synaptic pathology, Golgi apparatus in dementias. Special interests: Neuroethics, Neurolinguistics, Neurophilosophy, History of Neurosciences, Neurology and the Art. Member of 60 scientific societies. Honorary Member of the Academy of Hellenic Air Forces. President of the Society for the amelioration of the quality of life in chronic neurological diseases. President of the Orthodox Association for medical education and health in Africa. Visiting professor Tufts University, Democritus University, Aristotelian University, School of Theology, School of Philosophy. Author of 28 textbooks and 723 papers on Neurology and Neurosciences. Organized 26 International congresses and participated in 612 world congresses of Neurology, Neuropathology, Psychiatry and Medical Ethics. Author of two books of poems. Head of the department of Neurology (1992-2011) and Director of Research Institute for Alzheimer’s disease.
University of South California, USA
I work in academia as an internationally recognized neuropharmacology and neuroimmunology researcher. I published more than 500 scientific reports in the field of neuropsychopharmacology and signal transduction . I am leading a laboratory interested in understanding the fundamental neurobiological mechanisms of neuropsychiatric disorders to contribute at development of new pharmacological treatments. We use genetic, neuroendocrine and neurochemical methods. We recognize the role of the immune system in modulating neuropsychiatric diseases and we are developing in vitro cellular models and in vivo animal models to study the neuro-immune interactions under normal and disease states I has successfully combined research, teaching, administration and clinical care and continue to work on advancing our understanding of serious mental illness and drug development. We used to translate research findings into medical practice for the purposes of diagnosing, preventing and treating diseases. I has published scientific reports on peptides, their receptors, signal transduction and the role of these neuropeptides in the immune systems. I hold patents for using modified peptides in the treatment of septic shock. I have skills and expertise in receptor pharmacology, immunohistochemistry, in vivo and in vitro cell culture, biochemistry, animal models, cell and molecular biology. I has lectured worldwide on these subjects and the others. I have 19 years of research experience with development and use of in vitro models to test compounds, such as receptor binding, receptor activation, signal transduction, receptor-receptor interactions, and induction of changes in cell cycle, proliferation and apoptosis. Furthermore I validated appropriate assays and models of diseases, screen compounds, and study mechanisms of action.